Weed (BUDZ) Assets Average (2011 - 2026)
Weed's (BUDZ) quarterly Assets Average came in at $537809.5 in Q1 2026, down 18.11% year-on-year from $656747.0 in Q1 2025, and down 1.52% quarter-over-quarter from $546086.5 in Q4 2025.
Weed (BUDZ) Assets Average (2011 - 2026) Analysis & Trends
Weed's Assets Average history runs 11 years deep, the most recent figure standing at $537809.5 for Q1 2026.
- On a quarterly basis, Assets Average fell 18.11% year-over-year to $537809.5 in Q1 2026; TTM through Mar 2026 was $537809.5, a 18.11% decrease from a year earlier, with the FY2025 full-year figure at $649136.0, down 20.95% from the prior year.
- Assets Average eased to $537809.5 in Q1 2026 per BUDZ's latest filing, from $546086.5 in the prior quarter.
- Across five years, Assets Average topped out at $2.6 million in Q3 2022 and bottomed at $537809.5 in Q1 2026.
- The 5-year median for Assets Average is $803934.5 (2024), against an average of $1.2 million.
- Across the five-year window, Assets Average soared 42.86% in 2022 and sank 53.56% in 2024, its largest moves.
- Year by year, Assets Average stood at $2.0 million in 2022, then plunged by 46.53% to $1.1 million in 2023, then sank by 38.75% to $667592.0 in 2024, then declined by 18.2% to $546086.5 in 2025, then dropped by 1.52% to $537809.5 in 2026.
- Per Business Quant, the three latest BUDZ Assets Average figures stand at $537809.5 (Q1 2026), $546086.5 (Q4 2025), and $540586.5 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 537,809.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 537,809.50 |
| Dec 31, 2025 | 546,086.50 |
| Sep 30, 2025 | 540,586.50 |
| Jun 30, 2025 | 562,017.00 |
| Mar 31, 2025 | 656,747.00 |
| Dec 31, 2024 | 667,592.00 |
| Sep 30, 2024 | 600,057.00 |
| Jun 30, 2024 | 653,551.50 |
| Mar 31, 2024 | 803,934.50 |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 1.87 Mn |